Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk
Background: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of t...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
27 October 2011
|
| In: |
British journal of cancer
Year: 2011, Volume: 105, Issue: 12, Pages: 1934-1939 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/bjc.2011.448 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2011.448 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2011448 
|
| Author Notes: | K.N. Stevens, M. Garcia-Closas, Z. Fredericksen, M. Kosel, V.S. Pankratz, J.L. Hopper, G.S. Dite, C. Apicella, M.C. Southey, M.K. Schmidt, A. Broeks, L.J. Van ‘t Veer, R.a.E.M. Tollenaar, P.A. Fasching, M.W. Beckmann, A. Hein, A.B. Ekici, N. Johnson, J. Peto, I. dos Santos Silva, L. Gibson, E. Sawyer, I. Tomlinson, M.J. Kerin, S. Chanock, J. Lissowska, D.J. Hunter, R.N. Hoover, G.D. Thomas, R.L. Milne, J.I. Arias Pérez, A. González-Neira, J. Benítez, B. Burwinkel, A. Meindl, R.K. Schmutzler, C.R. Bartrar, U. Hamann, Y. D. Ko, T. Brüning, J. Chang-Claude, R. Hein, S. Wang-Gohrke, T. Dörk, P. Schürmann, M. Bremer, P. Hillemanns, N. Bogdanova, J.V. Zalutsky, Y.I. Rogov, N. Antonenkova, A. Lindblom, S. Margolin, A. Mannermaa, V. Kataja, V.-M. Kosma, J. Hartikainen, G. Chenevix-Trench, X. Chen, P. Peterlongo, B. Bonanni, L. Bernard, S. Manoukian, X. Wang, J. Cerhan, C.M. Vachon, J. Olson, G.G. Giles, L. Baglietto, C.A. McLean, G. Severi, E.M. John, A. Miron, R. Winqvist, K. Pylkäs, A. Jukkola-Vuorinen, M. Grip, I. Andrulis, J.A. Knight, G. Glendon, A.M. Mulligan, A. Cox, I.W. Brock, G. Elliott, S.S. Cross, P.P. Pharoah, A.M. Dunning, K.A. Pooley, M.K. Humphreys, J. Wang, D. Kang, K.-Y. Yoo, D.-Y. Noh, S. Sangrajrang, V. Gabrieau, P. Brennan, J. McKay, H. Anton-Culver, A. Ziogas, F.J. Couch and D.F. Easton the GENICA Network, kConFab Investigators, Australian Ovarian Cancer Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1819636585 | ||
| 003 | DE-627 | ||
| 005 | 20230710110140.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221021s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/bjc.2011.448 |2 doi | |
| 035 | |a (DE-627)1819636585 | ||
| 035 | |a (DE-599)KXP1819636585 | ||
| 035 | |a (OCoLC)1389765713 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Stevens, Kristen N. |e VerfasserIn |0 (DE-588)118766474X |0 (DE-627)1666586595 |4 aut | |
| 245 | 1 | 0 | |a Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |c K.N. Stevens, M. Garcia-Closas, Z. Fredericksen, M. Kosel, V.S. Pankratz, J.L. Hopper, G.S. Dite, C. Apicella, M.C. Southey, M.K. Schmidt, A. Broeks, L.J. Van ‘t Veer, R.a.E.M. Tollenaar, P.A. Fasching, M.W. Beckmann, A. Hein, A.B. Ekici, N. Johnson, J. Peto, I. dos Santos Silva, L. Gibson, E. Sawyer, I. Tomlinson, M.J. Kerin, S. Chanock, J. Lissowska, D.J. Hunter, R.N. Hoover, G.D. Thomas, R.L. Milne, J.I. Arias Pérez, A. González-Neira, J. Benítez, B. Burwinkel, A. Meindl, R.K. Schmutzler, C.R. Bartrar, U. Hamann, Y. D. Ko, T. Brüning, J. Chang-Claude, R. Hein, S. Wang-Gohrke, T. Dörk, P. Schürmann, M. Bremer, P. Hillemanns, N. Bogdanova, J.V. Zalutsky, Y.I. Rogov, N. Antonenkova, A. Lindblom, S. Margolin, A. Mannermaa, V. Kataja, V.-M. Kosma, J. Hartikainen, G. Chenevix-Trench, X. Chen, P. Peterlongo, B. Bonanni, L. Bernard, S. Manoukian, X. Wang, J. Cerhan, C.M. Vachon, J. Olson, G.G. Giles, L. Baglietto, C.A. McLean, G. Severi, E.M. John, A. Miron, R. Winqvist, K. Pylkäs, A. Jukkola-Vuorinen, M. Grip, I. Andrulis, J.A. Knight, G. Glendon, A.M. Mulligan, A. Cox, I.W. Brock, G. Elliott, S.S. Cross, P.P. Pharoah, A.M. Dunning, K.A. Pooley, M.K. Humphreys, J. Wang, D. Kang, K.-Y. Yoo, D.-Y. Noh, S. Sangrajrang, V. Gabrieau, P. Brennan, J. McKay, H. Anton-Culver, A. Ziogas, F.J. Couch and D.F. Easton the GENICA Network, kConFab Investigators, Australian Ovarian Cancer Study Group |
| 246 | 3 | 0 | |a three |
| 264 | 1 | |c 27 October 2011 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 21.10.2022 | ||
| 520 | |a Background: Somatic mutations in phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) are frequent in breast tumours and have been associated with oestrogen receptor (ER) expression, human epidermal growth factor receptor-2 overexpression, lymph node metastasis and poor survival. The goal of this study was to evaluate the association between inherited variation in this oncogene and risk of breast cancer. Methods: A single-nucleotide polymorphism from the PIK3CA locus that was associated with breast cancer in a study of Caucasian breast cancer cases and controls from the Mayo Clinic (MCBCS) was genotyped in 5436 cases and 5280 controls from the Cancer Genetic Markers of Susceptibility (CGEMS) study and in 30 949 cases and 29 788 controls from the Breast Cancer Association Consortium (BCAC). Results: Rs1607237 was significantly associated with a decreased risk of breast cancer in MCBCS, CGEMS and all studies of white Europeans combined (odds ratio (OR)=0.97, 95% confidence interval (CI) 0.95–0.99, P=4.6 × 10−3), but did not reach significance in the BCAC replication study alone (OR=0.98, 95% CI 0.96–1.01, P=0.139). Conclusion: Common germline variation in PIK3CA does not have a strong influence on the risk of breast cancer. | ||
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a Cancer genetics | |
| 650 | 4 | |a Genetic predisposition to disease | |
| 700 | 1 | |a Burwinkel, Barbara |d 1969- |e VerfasserIn |0 (DE-588)120685760 |0 (DE-627)704924005 |0 (DE-576)292337752 |4 aut | |
| 700 | 1 | |a Hamann, Ute |e VerfasserIn |0 (DE-588)1074024230 |0 (DE-627)830169970 |0 (DE-576)161285090 |4 aut | |
| 700 | 1 | |a Chang-Claude, Jenny |e VerfasserIn |0 (DE-588)1049304993 |0 (DE-627)781626188 |0 (DE-576)168344475 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1947 |g 105(2011), 12, Seite 1934-1939 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnas |a Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| 773 | 1 | 8 | |g volume:105 |g year:2011 |g number:12 |g pages:1934-1939 |g extent:6 |a Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| 856 | 4 | 0 | |u https://doi.org/10.1038/bjc.2011.448 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/bjc2011448 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221021 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 1049304993 |a Chang-Claude, Jenny |m 1049304993:Chang-Claude, Jenny |d 50000 |e 50000PC1049304993 |k 0/50000/ |p 41 | ||
| 998 | |g 1074024230 |a Hamann, Ute |m 1074024230:Hamann, Ute |d 50000 |e 50000PH1074024230 |k 0/50000/ |p 38 | ||
| 998 | |g 120685760 |a Burwinkel, Barbara |m 120685760:Burwinkel, Barbara |d 910000 |d 910400 |d 60000 |e 910000PB120685760 |e 910400PB120685760 |e 60000PB120685760 |k 0/910000/ |k 1/910000/910400/ |k 0/60000/ |p 34 | ||
| 999 | |a KXP-PPN1819636585 |e 4200618125 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"language":["eng"],"part":{"extent":"6","volume":"105","text":"105(2011), 12, Seite 1934-1939","issue":"12","year":"2011","pages":"1934-1939"},"titleAlt":[{"title":"BJC"}],"recId":"320420094","physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1532-1827"],"zdb":["2002452-6"],"eki":["320420094"]},"note":["Gesehen am 27.10.25"],"origin":[{"publisherPlace":"Edinburgh ; Edinburgh","dateIssuedDisp":"1947-","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedKey":"1947"}],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"title":[{"subtitle":"BJC","title_sort":"British journal of cancer","title":"British journal of cancer"}],"disp":"Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer riskBritish journal of cancer","type":{"media":"Online-Ressource","bibl":"periodical"}}],"recId":"1819636585","name":{"displayForm":["K.N. Stevens, M. Garcia-Closas, Z. Fredericksen, M. Kosel, V.S. Pankratz, J.L. Hopper, G.S. Dite, C. Apicella, M.C. Southey, M.K. Schmidt, A. Broeks, L.J. Van ‘t Veer, R.a.E.M. Tollenaar, P.A. Fasching, M.W. Beckmann, A. Hein, A.B. Ekici, N. Johnson, J. Peto, I. dos Santos Silva, L. Gibson, E. Sawyer, I. Tomlinson, M.J. Kerin, S. Chanock, J. Lissowska, D.J. Hunter, R.N. Hoover, G.D. Thomas, R.L. Milne, J.I. Arias Pérez, A. González-Neira, J. Benítez, B. Burwinkel, A. Meindl, R.K. Schmutzler, C.R. Bartrar, U. Hamann, Y. D. Ko, T. Brüning, J. Chang-Claude, R. Hein, S. Wang-Gohrke, T. Dörk, P. Schürmann, M. Bremer, P. Hillemanns, N. Bogdanova, J.V. Zalutsky, Y.I. Rogov, N. Antonenkova, A. Lindblom, S. Margolin, A. Mannermaa, V. Kataja, V.-M. Kosma, J. Hartikainen, G. Chenevix-Trench, X. Chen, P. Peterlongo, B. Bonanni, L. Bernard, S. Manoukian, X. Wang, J. Cerhan, C.M. Vachon, J. Olson, G.G. Giles, L. Baglietto, C.A. McLean, G. Severi, E.M. John, A. Miron, R. Winqvist, K. Pylkäs, A. Jukkola-Vuorinen, M. Grip, I. Andrulis, J.A. Knight, G. Glendon, A.M. Mulligan, A. Cox, I.W. Brock, G. Elliott, S.S. Cross, P.P. Pharoah, A.M. Dunning, K.A. Pooley, M.K. Humphreys, J. Wang, D. Kang, K.-Y. Yoo, D.-Y. Noh, S. Sangrajrang, V. Gabrieau, P. Brennan, J. McKay, H. Anton-Culver, A. Ziogas, F.J. Couch and D.F. Easton the GENICA Network, kConFab Investigators, Australian Ovarian Cancer Study Group"]},"physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1038/bjc.2011.448"],"eki":["1819636585"]},"note":["Gesehen am 21.10.2022"],"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"27 October 2011"}],"title":[{"title":"Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk","title_sort":"Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"given":"Kristen N.","role":"aut","display":"Stevens, Kristen N.","family":"Stevens"},{"display":"Burwinkel, Barbara","family":"Burwinkel","given":"Barbara","role":"aut"},{"role":"aut","given":"Ute","family":"Hamann","display":"Hamann, Ute"},{"given":"Jenny","role":"aut","family":"Chang-Claude","display":"Chang-Claude, Jenny"}]} | ||
| SRT | |a STEVENSKRIEVALUATION2720 | ||